We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+0.14%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$150M
AUM Growth
+$20.3M
Cap. Flow
+$15.7M
Cap. Flow %
10.5%
Top 10 Hldgs %
9.04%
Holding
664
New
292
Increased
44
Reduced
53
Closed
273

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.63%
2 Healthcare 14.32%
3 Technology 11.92%
4 Industrials 11.68%
5 Financials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MW
651
DELISTED
THE MENS WAREHOUSE INC
MW
-10,700
Closed -$157K
ZGNX
652
DELISTED
Zogenix, Inc.
ZGNX
-13,200
Closed -$195K
CA
653
DELISTED
CA, Inc.
CA
-14,000
Closed -$400K
SIVB
654
DELISTED
SVB Financial Group
SIVB
-2,900
Closed -$345K
WLL
655
DELISTED
Whiting Petroleum Corporation
WLL
-103
Closed -$293K
TRCO
656
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
-12,500
Closed -$423K
ACAS
657
DELISTED
American Capital Ltd
ACAS
-21,200
Closed -$292K
PLCM
658
DELISTED
POLYCOM INC
PLCM
-14,900
Closed -$188K
KKD
659
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
-14,700
Closed -$222K
ETP
660
DELISTED
Energy Transfer Partners L.p.
ETP
-8,600
Closed -$290K
TIVO
661
DELISTED
TIVO INC
TIVO
-10,900
Closed -$94K
ARMH
662
DELISTED
ARM HOLDINGS PLC ADS
ARMH
-5,000
Closed -$226K
AZPN
663
DELISTED
ASPEN TECHNOLOGY INC
AZPN
-13,100
Closed -$495K
TCF
664
DELISTED
TCF Financial Corporation
TCF
-13,600
Closed -$192K

Similar funds

Fox Run Management's Q1 2016 Portfolio in Review

As of Q1 2016, Fox Run Management held 664 positions worth $150M, up 16% from $129M the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Fox Run Management deployed $15.7M of net new capital in Q1 2016, opening 292 new positions and adding to 44 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 2,700 shares worth $973K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.43M trimmed.

  • Fox Run Management's largest Q1 2016 buy was Regeneron Pharmaceuticals: 2,700 shares worth $973K.
  • Fox Run Management added most to Hologic in Q1 2016, an estimated $823K increase.
  • Fox Run Management's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.43M.
  • Fox Run Management fully exited Enterprise Products Partners in Q1 2016, selling an estimated $1.02M.
  • Fox Run Management's ten largest holdings make up 9% of its $150M portfolio in Q1 2016.
  • Fox Run Management opened 292 new positions and closed 273 in Q1 2016.
  • Fox Run Management's portfolio value rose 16% quarter-over-quarter to $150M.

Based on Fox Run Management's 13F filing for Q1 2016, filed 18 Apr 2016.